Live Breaking News & Updates on Induced Nausea|Page 2

Stay updated with breaking news from Induced nausea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tetra Bio-Pharma: Health Canada Accepts New Drug Submission for REDUVO as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting


Tetra Bio-Pharma: Health Canada Accepts New Drug Submission for REDUVO as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting
The Company approaches a significant milestone advancing from a pre-revenue biotech to in revenue
OTTAWA, ON / ACCESSWIRE / June 2, 2021 /
Tetra Bio-Pharma
Inc. ( Tetra or the
Company ) (TSX:TBP) (OTCQB:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development announced today that Health Canada has accepted its New Drug Submission (NDS) for REDUVO and has formally entered the final review phase in the drug review process. If successful, REDUVO will be issued a Notice of Compliance (NOC) as well as a Drug Identification Number (DIN) which permits Tetra to market the drug in Canada and indicates the drug s official approval in Canada. ....

Natalie Leroux , Tetra Bio Pharma Inc , Health Canada , Regulation Services Provider , Tetra Bio Pharma , New Drug Submission , Drug Identification Number , Chief Executive Officer , Induced Nausea , நடாலி லேரௌுக்ஷ , டெட்ரா உயிர் பார்மா இன்க் , ஆரோக்கியம் கனடா , ஒழுங்குமுறை சேவைகள் வழங்குநர் , டெட்ரா உயிர் பார்மா , புதியது மருந்து சமர்ப்பிப்பு , மருந்து அடையாளம் எண் , தலைமை நிர்வாகி அதிகாரி ,